NCT01496053View on ClinicalTrials.gov

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease
Interventions
DIETARY_SUPPLEMENT

AndoSan

AndoSan 30 ml x 2 for 21 days

DIETARY_SUPPLEMENT

Sugar Extract

Sham comparator

Trial Locations (1)

0407

Oslo University Hospital, Ulleval, Oslo

Sponsors

Collaborators (1)

ImmunoPharma AS
All Listed Sponsors
collaborator

ImmunoPharma AS

INDUSTRY

lead

Oslo University Hospital

OTHER